Position in AMRX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,160,787
+$39,299 QoQ
Shares Held
93,386
+4.9% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HighTower Advisors, LLC holds $76,791,783 across 32 Drug Manufacturers - Specialty & Generic names. AMRX ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
419,904 | $49,636,851 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
224,067 | $6,748,898 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
4,894 | $2,902,044 | |
| 4 | HLN |
Haleon plc
|
192,177 | $1,923,691 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
103,082 | $1,909,078 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
11,198 | $1,475,224 | |
| 7 | VTRS |
Viatris Inc
|
108,052 | $1,459,782 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
93,386 | $1,160,787 |
All Filings in AMRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,160,787 | 93,386 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,121,488 | 89,007 | Shares | Sole | 2026-02-06 | |
| 2024-09-30 | $101,437 | 12,192 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $83,839 | 13,203 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||